An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (Thelin®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension

✍ Scribed by Keith Owen; David M. Cross; Mazin Derzi; Elizabeth Horsley; Fiona L. Stavros

• Book ID: 116991835
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 225 KB
• Volume: 64
• Category: Article
• ISSN: 0273-2300
• DOI: 10.1016/j.yrtph.2012.05.017